Skip to main content
AAPL-0.23%NVDA-1.01%MSFT-0.39%GOOGL-0.98%AMZN-0.83%TSM-1.67%SPCX-0.59%AVGO-4.76%META-0.69%TSLA-0.77%LLY+1.14%BRK-B+0.53%WMT+1.51%SKHY-4.30%JPM+0.98%MU-2.04%AMD-8.75%V+1.30%XOM+0.48%JNJ+0.79%MA+1.32%ASMLa-2.76%ABBV+0.20%COST+1.28%1398.HK+1.02%0700.HK-3.06%CVX+1.64%KO+1.86%PG+1.05%ORCL-1.38%CSCO-6.24%UNH+0.58%0939.HK+0.57%BAC+1.01%HD+0.12%GE+0.29%3988.HK+0.64%0857.HK+2.79%1816.HK+0.65%INTC-2.52%PM+1.17%1288.HK+1.18%0005.HK-0.57%HSBA.L+0.03%NVS+0.16%MS+0.78%AMAT-2.74%AZN+0.04%AP2d-8.10%LRCX-3.36%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%NZDMXN0.00%GBPSGD0.00%EURNOK0.00%GBPCHF0.00%PLNJPY0.00%CHFNOK0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%CHFJPY0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPAUD0.00%GBPNZD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURPLN0.00%EURCAD0.00%EURUSD0.00%EURJPY0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.53%ETHUSD+62.73%USDTUSD+0.02%XRPUSD+64.19%SOLUSD+68.57%TRXUSDT-0.46%ZECUSDT+4.55%DOGEUSD+63.45%XMRUSDT+5.51%LINKUSD+4.35%XLMUSD+3.56%BCHUSDT+3.88%LTCUSD+50.45%UNIUSD+5.70%SUIUSD+4.30%TONUSD+64.57%HBARUSDT+4.84%TAOUSDT+4.83%AAVEUSD+8.30%ICPUSDT+2.40%DOTUSDT+3.56%ONDOUSDT+4.17%JUPUSDT+7.34%ARBUSDT+5.08%WLDUSDT+4.61%INJUSDT+2.58%ATOMUSDT+3.55%STXUSDT+1.45%PYTHUSDT+2.50%TIAUSDT+3.70%FETUSDT+3.40%SEIUSDT+5.01%IMXUSDT+1.68%GRTUSDT+3.88%OPUSDT+2.16%POLUSDT+2.74%WIFUSDT+3.28%IOTAUSDT+1.28%AXSUSDT+2.18%EOSUSDT+7.20%FARTCOINUSDT+5.20%DYDXUSDT+2.65%GALAUSDT+4.21%ORDIUSDT+4.30%NOTUSDT+4.97%RONINUSDT+0.94%AAPL-0.23%NVDA-1.01%MSFT-0.39%GOOGL-0.98%AMZN-0.83%TSM-1.67%SPCX-0.59%AVGO-4.76%META-0.69%TSLA-0.77%LLY+1.14%BRK-B+0.53%WMT+1.51%SKHY-4.30%JPM+0.98%MU-2.04%AMD-8.75%V+1.30%XOM+0.48%JNJ+0.79%MA+1.32%ASMLa-2.76%ABBV+0.20%COST+1.28%1398.HK+1.02%0700.HK-3.06%CVX+1.64%KO+1.86%PG+1.05%ORCL-1.38%CSCO-6.24%UNH+0.58%0939.HK+0.57%BAC+1.01%HD+0.12%GE+0.29%3988.HK+0.64%0857.HK+2.79%1816.HK+0.65%INTC-2.52%PM+1.17%1288.HK+1.18%0005.HK-0.57%HSBA.L+0.03%NVS+0.16%MS+0.78%AMAT-2.74%AZN+0.04%AP2d-8.10%LRCX-3.36%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%NZDMXN0.00%GBPSGD0.00%EURNOK0.00%GBPCHF0.00%PLNJPY0.00%CHFNOK0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%CADJPY0.00%EURSEK0.00%GBPUSD0.00%CHFJPY0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPAUD0.00%GBPNZD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURDKK0.00%NZDJPY0.00%EURPLN0.00%EURCAD0.00%EURUSD0.00%EURJPY0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.53%ETHUSD+62.73%USDTUSD+0.02%XRPUSD+64.19%SOLUSD+68.57%TRXUSDT-0.46%ZECUSDT+4.55%DOGEUSD+63.45%XMRUSDT+5.51%LINKUSD+4.35%XLMUSD+3.56%BCHUSDT+3.88%LTCUSD+50.45%UNIUSD+5.70%SUIUSD+4.30%TONUSD+64.57%HBARUSDT+4.84%TAOUSDT+4.83%AAVEUSD+8.30%ICPUSDT+2.40%DOTUSDT+3.56%ONDOUSDT+4.17%JUPUSDT+7.34%ARBUSDT+5.08%WLDUSDT+4.61%INJUSDT+2.58%ATOMUSDT+3.55%STXUSDT+1.45%PYTHUSDT+2.50%TIAUSDT+3.70%FETUSDT+3.40%SEIUSDT+5.01%IMXUSDT+1.68%GRTUSDT+3.88%OPUSDT+2.16%POLUSDT+2.74%WIFUSDT+3.28%IOTAUSDT+1.28%AXSUSDT+2.18%EOSUSDT+7.20%FARTCOINUSDT+5.20%DYDXUSDT+2.65%GALAUSDT+4.21%ORDIUSDT+4.30%NOTUSDT+4.97%RONINUSDT+0.94%
IM

ImmunityBio, Inc. (IBRX)

NASDAQ • Healthcare

$6.02
-$0.05 (-0.8%)
Market closed

Last close at November 13, 2026 at 21:00 UTC

Open$6.11
Day Range$5.83 - $6.17
Avg. Volume (3M)13.3M
Market Cap$6.4B
52 Week Range
$1.95$12.43

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$48.8M100%
Gross Profitminus cost of goods$47.5M97%

Fundamentals & Financials

Revenue (TTM)
$182.5M
Net Income (TTM)
-$1.1B
EPS (TTM)
-$1.07
ROA (TTM)
-182.09%
Current Ratio
4.27
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-675.0%Q2 2026-$0.62
-175.0%Q3 2026-$0.22
-142.9%Q4 2026-$0.17

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Miss -142.9%

ImmunityBio’s third fiscal quarter of 2026 results missed consensus on both revenue and adjusted EPS, as reported November 9, 2026, even as sales grew sharply year over year. Revenue rose 52.3% to roughly $48.8 million (up from about $32.1 million a year ago) but trailed expectations, coming in at $48.8 million versus a $59.2 million estimate (-17.5%). Adjusted EPS of -$0.17 also trailed the -$0.07 estimate by -$0.10 and was down from -$0.07 a year ago. Profitability remained pressured despite a gross margin of about 97%, with gross profit of roughly $47.5 million alongside an operating loss of about $78.0 million, translating to an operating margin near -160%. Net income was a loss of roughly $184.6 million, compared with a loss of about $67.3 million a year ago (-174.4%). For the next period, consensus calls for EPS of -$0.10 on revenue of $62.5 million.

View full earnings history

About ImmunityBio, Inc.

ImmunityBio, Inc. (NASDAQ: IBRX) is a biotechnology company that develops therapies and vaccines for cancer and infectious disease using immunotherapy and cell therapy platforms. In FY2025, it generated $113.3 million in revenue. Its programs span antibody-cytokine fusion proteins, immunomodulators, vaccine technologies, NK cell therapies, and T-cell strategies.

Name
ImmunityBio, Inc.
CEO
Richard Gerald Adcock
Industry
Healthcare
Year Founded
2014
Employees
688

Today's Snapshot

AI-generated

IBRX closed 0.8% lower at 6.02, against a firmer sector.

Trading Volume

Below 10d avg (15.8M)

13.2M

vs S&P 500 Today

Moderate Underperformance

-0.46%

Updated: November 13, 2026 at 21:10 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
IBRX presents a pronounced short-term breakdown, consistent with a strong sell reading. Momentum indicators and MACD are negative and the commodity channel index is deeply oversold, while price sits well below most short- and medium-term averages and beneath the 200-day level, signaling broad moving-average weakness. Trend strength is modest but not decisive, while volatility is elevated and the stock is trading around the lower Bollinger boundary, underscoring stressed action. On-balance volume does not support a recovery. Technical takeaway: pervasive moving-average and momentum weakness combined with high volatility yield a strong sell bias.
All signals
  • EMA (5 indicators)$7.17 - $8.25
    Sell
  • RSI (14)32.59
    Neutral
  • Stochastic %K (14, 3, 3)6.81
    Buy
  • MACD Level (12, 26)-0.65
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.